Skip to main content

< Events

Translational Research Seminar Series

Oct 262023

Translational Research Seminar Series

Leveraging Rich Transcriptomic Datasets to Address Outstanding Questions in Pediatric Leukemia Research

4:00 pm | Irina Pushel | Children's Mercy Kansas City

Webinar

Learn more

May 232023

Translational Research Seminar Series

Nutrition before and after cancer treatments: Current evidence and emerging approaches to improve outcomes

4:00 pm | Jill Hamilton-Reeves, Ph.D., R.D., C.S.O. | University of Kansas Medical Center

Children's Mercy Research Institute and Teams Livestream

Learn more

Colorful graphic depicting a genomic sequence

May 232023

Translational Research Seminar Series

Using Astyanax mexicanus as a model to investigate altered glucose metabolism

4:00 pm | Ansa Cobham, Ph.D. | Stowers Institute for Medical Research

Children's Mercy Research Institute and Teams Livestream

Learn more

Colorful graphic depicting a genomic sequence

Mar 302023

Translational Research Seminar Series

Neuroscience Drug Discovery in Ophthalmology

4:00 pm | Peter Koulen | University of Missouri – Kansas City

Webinar

Learn more

Mar 302023

Translational Research Seminar Series

Pomacea canaliculata: a new research organism to study camera eye regeneration

4:00 pm | Alice Accorsi | Stowers Institute for Medical Research

Webinar

Learn more

Dec 012022

Translational Research Seminar Series

Understanding the dynamic roles for RNA Polymerase I subunits in embryonic development and disease

4:00 pm | Kristin Watt, PhD Postdoctoral Researcher, Trainor Lab, Stowers Institute for Medical Research

Virtual Teams Meeting

Dec 012022

Translational Research Seminar Series

POLR1C-related disorders: Applying new technologies, dynamic analysis and expanding the clinical spectrum

4:00 pm | Isabelle Thiffault, PhD Director of Translational Genetics – Clinical lab, Children’s Mercy Research Institute

Virtual Teams Meeting

Sep 292022

Translational Research Seminar Series

Bench to Bedside and Back Again

4:00 pm | Scott Weir, PharmaD, PhD

Development of KU-Invented Fosciclopirox for the Treatment of Solid Tumor Cancers and Hematologic Malignancies.

Newsletter & Alerts